222
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

University students’ attributions for abstinence from synthetic cannabinoids and synthetic cathinones

, MA, , PhD & , PhD
Pages 64-72 | Received 04 Oct 2016, Accepted 26 Jan 2017, Published online: 07 Mar 2017

References

  • Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the Future national results on drug use: 1975–2013: overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan; 2014.
  • Meisel MK, Goodie AS. Predicting prescription drug misuse in college students’ social networks. Addict Behav 2015;45:110–112. doi:10.1016/j.addbeh.2015.01.025.
  • Kuntsche E, Knibbe R, Gmel G, Engels R. Why do young people drink? A review of drinking motives. Clin Psychol Rev 2005;25(7):841–861. doi:10.1016/j.cpr.2005.06.002.
  • Messina BG, Dutta NM, Silvestri MM, Diulio AR, Garza KB, Murphy JG, Correia CJ. Modeling motivations for non-medical use of prescription drugs. Addict Behav 2016;52:46–51. doi:10.1016/j.addbeh.2015.07.024.
  • Palamar JJ, Griffin-Tomas M, Kamboukos D. Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States. Am J Drug Alcohol Abuse 2015;41:323–331. doi:10.3109/00952990.2015.1045977.
  • Bargh JA, Chartrand TL. The unbearable automaticity of being. Am Psychol 1999;54:462–479. doi:10.1037/0003-066X.54.7.462.
  • Wilson TD, Dunn EW. Self-knowledge: its limits, value, and potential for improvement. Annu Rev Psychol 2004;55:493–518. doi:10.1146/annurev.psych.55.090902.141954.
  • Globetti E, Globetti G, Brown CL, Stem JT. Campus attitudes toward alcohol and drugs in a deep southern university. J Drug Educ 1992;22:203–213.
  • Huang JH, Dejong W, Schneider SK, Towvim LG. Endorsed reasons for not drinking alcohol: a comparison of college student drinkers and abstainers. J Behav Med 2011;34:64–73. doi:10.1007/s10865-010-9272-x.
  • McBride DC, Mutch PB, Chitwood DD. Religious belief and the initiation and prevention of drug use among youth. In: McCoy CB, Metsch JA, Inciardi JA, eds. Intervening with drug-involved youth. New York: SAGE Publications; 1996:110–130.
  • Rinker DV, Neighbors C. Reasons for not drinking and perceived injunctive norms as predictors of alcohol abstinence among college students. Addict Behav 2013;38:2261–2266. doi:10.1016/j.addbeh.2013.02.011.
  • Rosenberg H, Baylen C, Murray S, Phillips K, Tisak MS, Versland A, Pristas E Attributions for abstinence from illicit drugs by university students. Drugs Educ Prev Policy 2008;15:365–377.doi:10.1080/09687630701428976.
  • Rosenberg H, Bonar EE, Pavlick M, Jones LD, Hoffmann E, Murray S, Faigin CA, et al. Associations between University Students’ reported reasons for abstinence from illicit substances and type of drug. J Coll Stud Dev 2012;53:91–105. doi:10.1353/csd.2012.0010.
  • Terry-McElrath YM, O’Malley PM, Johnston LD. Saying no to marijuana: why American youth report quitting or abstaining. J Stud Alcohol Drugs 2008;69(6):796–805. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2583380&tool=pmcentrez&rendertype=abstract.
  • U.S. Drug Enforcement Administration, Office of Diversion Control. National forensic laboratory information system special report: synthetic cannabinoids and synthetic cathinones reported in NFLIS, 2010–2013. Springfield, VA: U.S. Drug Enforcement Administration; 2014.
  • Palamar JJ. “Bath Salt” use among a nationally representative sample of high school seniors in the United States. Am J Addict 2015;24:488–491. doi:10.1111/ajad.12254.
  • Palamar JJ, Acosta P. Synthetic cannabinoid use in a nationally representative sample of US high school seniors. Drug Alcohol Depend 2015;149:194–202. doi:10.1016/j.drugalcdep.2015.01.044.
  • Huffman JW, Dai D, Martin BR, Compton DR. Design, synthesis and pharmacology of cannabimimetic indoles. Bioorganic Med Chem Lett 1994;4:563–566. doi:10.1016/S0960-894X(01)80155-4.
  • Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N. ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 2009;44(5):832–837. doi:10.1002/jms.1558.
  • Barratt MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev 2013;32(2):141–146. doi:10.1111/j.1465-3362.2012.00519.x.
  • Castellanos D, Thornton G. Synthetic cannabinoid use: recognition and management. J Psychiatr Pract 2012;18(2):86–93. doi:10.1097/01.pra.0000413274.09305.9c.
  • Fattore L, Fratta W. Beyond THC: The new generation of cannabinoid designer drugs. Front Behav Neurosci 2011;5:60. doi:10.3389/fnbeh.2011.00060.
  • Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus 2014;35(2):184–189. doi:10.1080/08897077.2013.846288.
  • Kelly BC, Wells BE, Pawson M, Leclair A, Parsons JT, Golub SA. Novel psychoactive drug use among younger adults involved in US nightlife scenes. Drug Alcohol Rev 2013;32(6):588–593. doi:10.1111/dar.12058.
  • Davis C, Boddington D. Teenage cardiac arrest following abuse of synthetic cannabis. Heart Lung Circ 2015;24(10):e162–e163. doi:10.1016/j.hlc.2015.04.176.
  • Green B, Kavanagh D, Young R. Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 2003;22(4):453–460. doi:10.1080/09595230310001613976.
  • Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. “Spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict 2012;21(4):320–326. doi:10.1111/j.1521-0391.2012.00240.x.
  • Hermanns-Clausen M, Kneisel S, Szabo B, Auwarter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 2013;108(3):534–544. doi:10.1111/j.1360-0443.2012.04078.x.
  • Papanti D, Schifano F, Botteon G, Bertossi F, Mannix J, Vidoni D, Impagnatiello M, et al. “Spiceophrenia”: a systematic overview of “spice”-related psychopathological issues and a case report. Hum Psychopharmacol 2013;28:379–389. doi:10.1002/hup.2312.
  • Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuro-Psychopharmacology Biol Psychiatry 2012;39:234–243. doi:10.1016/j.pnpbp.2012.04.017.
  • Spaderna M, Addy PH, D’Souza DC. Spicing things up: synthetic cannabinoids. Psychopharmacology 2013;228:525–540. doi:10.1007/s00213-013-3188-4.
  • Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend 2012;120(1–3):238–241. doi:10.1016/j.drugalcdep.2011.07.011.
  • Baumann MH, Partilla JS, Lehner KR. Psychoactive “bath salts”: not so soothing. Eur J Pharmacol 2013;698(1–3):1–5. doi:10.1016/j.ejphar.2012.11.020.
  • Ashrafioun L, Bonadio FA, Baik K D, Bradbury SL, Carhart VL, Cross NA, Davis AK, et al. Patterns of use, acute subjective experiences, and motivations for using synthetic cathinones (“bath salts”) in recreational users. J Psychoactive Drugs 2016;48(5):336–343. doi:10.1080/02791072.2016.1229875.
  • Coppola M, Mondola R. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “ plant food.” Toxicol Lett 2012;211(2):144–149. doi:10.1016/j.toxlet.2012.03.009.
  • Johnson PS, Johnson MW. Investigation of “bath salts” use patterns within an online sample of users in the United States. J Psychoactive Drugs 2014;46(5):369–378. doi:10.1080/02791072.2014.962717.
  • Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow… and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (Bath Salts), kratom, salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012;8:15–32. doi:10.1007/s13181-011-0202-2.
  • Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F. Mephedrone, new kid for the chop? Addiction 2011;106:154–161. doi:10.1111/j.1360-0443.2010.03130.x.
  • Winder GS, Stern N, Hosanagar A. Are “Bath Salts” the next generation of stimulant abuse? J Subst Abuse Treat 2013;44:42–45. doi:10.1016/j.jsat.2012.02.003.
  • Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2012;8:33–42. doi:10.1007/s13181-011-0193-z.
  • Ross EA, Watson M, Goldberger B. “Bath salts” intoxication. N Engl J Med 2011;365:967–968. doi:10.1056/NEJMc1107097.
  • Spiller HA, Ryan ML, Weston RG, Jansen J. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol 2011;49:499–505.
  • Stogner JM, Miller BL. Investigating the “bath salt” panic: the rarity of synthetic cathinone use among students in the United States. Drug Alcohol Rev 2013;32:545–549. doi:10.1111/dar.12055.
  • Egan KL, Suerken CK, Reboussin BA, Spangler J, Wagoner KG, Sutfin EL, Debinski B, Wolfson M, et al. K2 and Spice use among a cohort of college students in southeast region of the USA. Am J Drug Alcohol Abuse 2015;41:317–322. doi:10.3109/00952990.2015.1043438.
  • King DB, O’Rourke N, DeLongis A. Social media recruitment and online data collection: a beginner’s guide and best practices for accessing low-prevalence and hard-to-reach populations. Can Psychol Can 2014;55:240–249. doi:10.1037/a0038087.
  • Ramo DE, Liu H, Prochaska JJ. Reliability and validity of young adults’ anonymous online reports of marijuana use and thoughts about use. Psychol Addict Behav 2012;26:801–811. doi:10.1037/a0026201.
  • American Association of Poison Control Centers. Synthetic Cannabinoid Data. Available at: https://aapcc.s3.amazonaws.com/files/library/Syn_Marijuana_Web_Data_through_11.30.16.pdf Published November 2016. [last accessed Jan 2017].
  • American Associate of Poison Control Centers. Bath Salts Data. Available at: https://aapcc.s3.amazonaws.com/files/library/Bath_Salts_Web_Data_through_11.2016.pdf Published November 2016 [last accessed Jan 2017].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.